12:00 AM
 | 
May 14, 2012
 |  BC Week In Review  |  Company News  |  Deals

Ligand, Vertex deal

Ligand said in its 1Q12 earnings that it partnered with Vertex in a deal regarding Ligand's Captisol modified...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >